Magazine
Latest Issue

Vioxx: nobody's painkiller of choice

Good news today for those in Britain fighting for compensation from US drug giant Merck. As Jim Giles reported in January, relatives of British people who suffered heart attacks and other health problems after taking Merck’s deadly painkiller, Vioxx, had been told that they could not pursue their claims in court because they were not US residents. Despite the multinational having paid out more than £2bn to 44,000 people in America, the British government declined to help…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to letters@prospect-magazine.co.uk

More From Prospect